OMEROS CORP Investing Cash Flow
OMEROS CORP (OMER) reported Investing Cash Flow of $32.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- OMEROS CORP net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $3.40M, a 84.04% decline year-over-year.
- OMEROS CORP net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $28.73M, a 25.45% decline year-over-year.
- OMEROS CORP net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $111.55M, a 219.12% increase year-over-year.
- OMEROS CORP net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$6.86M, a 119.04% decline year-over-year.
- OMEROS CORP net cash provided by (used in) investing activities for fiscal 2025 was $164.52M, a 100.11% increase from fiscal 2024.
- OMEROS CORP net cash provided by (used in) investing activities for fiscal 2024 was $82.22M, a 199.47% increase from fiscal 2023.
- OMEROS CORP net cash provided by (used in) investing activities for fiscal 2023 was $27.45M.
- OMEROS CORP net cash provided by (used in) investing activities for fiscal 2022 was -$127.56M, a 165.85% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 204 month | Net Cash Provided by (Used in) Investing Activities 207 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $32.13M 10-Q · filed 2026-08-12 | $143.68M derived: sum of 3 quarters · filed 2026-08-12 | $136.82M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $28.73M 10-Q · filed 2026-05-13 | $140.28M derived: sum of 2 quarters · filed 2026-05-13 | $133.42M derived: sum of 3 quarters · filed 2026-05-13 | $154.72M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $111.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $104.69M derived: sum of 2 quarters · filed 2026-03-31 | $125.98M derived: sum of 3 quarters · filed 2026-08-12 | $164.52M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$6.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $14.44M derived: sum of 2 quarters · filed 2026-08-12 | $52.98M 10-Q · filed 2025-11-13 | $87.93M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $21.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $59.84M 10-Q · filed 2026-08-12 | $94.79M derived: sum of 3 quarters · filed 2026-08-12 | $130.83M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $38.54M 10-Q · filed 2026-05-13 | $73.50M derived: sum of 2 quarters · filed 2026-05-13 | $109.53M derived: sum of 3 quarters · filed 2026-05-13 | $182.68M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $34.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $70.99M derived: sum of 2 quarters · filed 2026-03-31 | $144.14M derived: sum of 3 quarters · filed 2026-03-31 | $82.22M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $36.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $109.19M derived: sum of 2 quarters · filed 2025-11-13 | $47.26M 10-Q · filed 2025-11-13 | $163.51M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-06-30 | $73.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $11.22M 10-Q · filed 2025-08-14 | $127.47M derived: sum of 3 quarters · filed 2026-03-31 | $184.63M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-03-31 | -$61.92M 10-Q · filed 2025-05-15 | $54.32M derived: sum of 2 quarters · filed 2026-03-31 | $111.48M derived: sum of 3 quarters · filed 2026-03-31 | $146.86M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2023-12-31 | $116.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $173.41M derived: sum of 2 quarters · filed 2026-03-31 | $208.78M derived: sum of 3 quarters · filed 2026-03-31 | $27.45M 10-K · filed 2026-03-31 | ||
| 2023-09-30 | $57.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $92.54M derived: sum of 2 quarters · filed 2024-11-13 | -$88.79M 10-Q · filed 2024-11-13 | -$197.28M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-06-30 | $35.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$145.96M 10-Q · filed 2024-08-07 | -$254.45M derived: sum of 3 quarters · filed 2025-03-31 | -$221.45M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-03-31 | -$181.33M 10-Q · filed 2024-05-15 | -$289.82M derived: sum of 2 quarters · filed 2025-03-31 | -$256.82M derived: sum of 3 quarters · filed 2025-03-31 | -$232.08M derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2022-12-31 | -$108.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$75.49M derived: sum of 2 quarters · filed 2025-03-31 | -$50.75M derived: sum of 3 quarters · filed 2025-03-31 | -$127.56M 10-K · filed 2025-03-31 | ||
| 2022-09-30 | $33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $57.74M derived: sum of 2 quarters · filed 2023-11-09 | -$19.07M 10-Q · filed 2023-11-09 | $93.34M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-06-30 | $24.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$52.07M 10-Q · filed 2023-08-09 | $60.35M derived: sum of 3 quarters · filed 2024-04-01 | $78.24M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2022-03-31 | -$76.81M 10-Q · filed 2023-05-09 | $35.60M derived: sum of 2 quarters · filed 2024-04-01 | $53.50M derived: sum of 3 quarters · filed 2024-04-01 | $83.91M derived: sum of 4 quarters · filed 2024-04-01 | ||
| 2021-12-31 | $112.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $130.31M derived: sum of 2 quarters · filed 2024-04-01 | $160.72M derived: sum of 3 quarters · filed 2024-04-01 | $193.71M 10-K · filed 2024-04-01 | ||
| 2021-09-30 | $17.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $48.31M derived: sum of 2 quarters · filed 2022-11-09 | $81.29M 10-Q · filed 2022-11-09 | $89.29M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-06-30 | $30.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $63.40M 10-Q · filed 2022-08-09 | $71.39M derived: sum of 3 quarters · filed 2023-03-13 | -$47.01M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2021-03-31 | $32.98M 10-Q · filed 2022-05-10 | $40.98M derived: sum of 2 quarters · filed 2023-03-13 | -$77.42M derived: sum of 3 quarters · filed 2023-03-13 | -$44.82M derived: sum of 4 quarters · filed 2023-03-13 | ||
| 2020-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$110.40M derived: sum of 2 quarters · filed 2023-03-13 | -$77.81M derived: sum of 3 quarters · filed 2023-03-13 | -$67.03M 10-K · filed 2023-03-13 | ||
| 2020-09-30 | -$118.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$85.80M derived: sum of 2 quarters · filed 2021-11-09 | -$75.03M 10-Q · filed 2021-11-09 | -$114.27M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $32.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $43.37M 10-Q · filed 2021-08-09 | $4.13M derived: sum of 3 quarters · filed 2022-03-01 | $13.47M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $10.78M 10-Q · filed 2021-05-10 | -$28.46M derived: sum of 2 quarters · filed 2022-03-01 | -$19.12M derived: sum of 3 quarters · filed 2022-03-01 | -$3.91M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$39.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$29.90M derived: sum of 2 quarters · filed 2022-03-01 | -$14.69M derived: sum of 3 quarters · filed 2022-03-01 | -$3.40M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $9.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $24.55M derived: sum of 2 quarters · filed 2020-11-09 | $35.84M 10-Q · filed 2020-11-09 | $33.48M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $15.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $26.50M 10-Q · filed 2020-08-10 | $24.14M derived: sum of 3 quarters · filed 2021-03-01 | $57.20M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $11.29M 10-Q · filed 2020-05-11 | $8.93M derived: sum of 2 quarters · filed 2021-03-01 | $41.99M derived: sum of 3 quarters · filed 2021-03-01 | $27.89M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $30.70M derived: sum of 2 quarters · filed 2021-03-01 | $16.60M derived: sum of 3 quarters · filed 2021-03-01 | $25.15M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $33.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $18.96M derived: sum of 2 quarters · filed 2019-11-12 | $27.51M 10-Q · filed 2019-11-12 | $32.94M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$5.55M 10-Q · filed 2019-08-08 | -$120.00K derived: sum of 3 quarters · filed 2020-03-02 | -$59.66M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $8.55M 10-Q · filed 2019-05-09 | $13.98M derived: sum of 2 quarters · filed 2020-03-02 | -$45.56M derived: sum of 3 quarters · filed 2020-03-02 | -$39.72M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$54.11M derived: sum of 2 quarters · filed 2020-03-02 | -$48.26M derived: sum of 3 quarters · filed 2020-03-02 | -$37.60M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$59.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$53.69M derived: sum of 2 quarters · filed 2018-11-08 | -$43.03M 10-Q · filed 2018-11-08 | -$49.04M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $5.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $16.51M 10-Q · filed 2018-08-09 | $10.50M derived: sum of 3 quarters · filed 2019-03-01 | -$10.04M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $10.66M 10-Q · filed 2018-05-10 | $4.65M derived: sum of 2 quarters · filed 2019-03-01 | -$15.89M derived: sum of 3 quarters · filed 2019-03-01 | -$20.30M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$26.55M derived: sum of 2 quarters · filed 2019-03-01 | -$30.97M derived: sum of 3 quarters · filed 2019-03-01 | -$16.34M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$20.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$24.96M derived: sum of 2 quarters · filed 2017-11-09 | -$10.32M 10-Q · filed 2017-11-09 | -$2.88M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $10.22M 10-Q · filed 2017-08-08 | $17.66M derived: sum of 3 quarters · filed 2018-03-01 | $32.08M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $14.63M 10-Q · filed 2017-05-10 | $22.08M derived: sum of 2 quarters · filed 2018-03-01 | $36.49M derived: sum of 3 quarters · filed 2018-03-01 | $56.12M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $21.86M derived: sum of 2 quarters · filed 2018-03-01 | $41.48M derived: sum of 3 quarters · filed 2018-03-01 | -$20.61M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $14.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $34.04M derived: sum of 2 quarters · filed 2016-11-09 | -$28.05M 10-Q · filed 2016-11-09 | -$13.57M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $19.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$42.47M 10-Q · filed 2016-08-09 | -$27.98M derived: sum of 3 quarters · filed 2017-03-16 | -$13.10M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | -$62.09M 10-Q · filed 2016-05-10 | -$47.61M derived: sum of 2 quarters · filed 2017-03-16 | -$32.72M derived: sum of 3 quarters · filed 2017-03-16 | -$17.02M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $14.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $29.37M derived: sum of 2 quarters · filed 2017-03-16 | $45.07M derived: sum of 3 quarters · filed 2017-03-16 | $6.16M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $14.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $30.59M derived: sum of 2 quarters · filed 2015-11-09 | -$8.32M 10-Q · filed 2015-11-09 | -$13.26M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $15.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$23.21M 10-Q · filed 2015-08-10 | -$28.15M derived: sum of 3 quarters · filed 2016-03-15 | -$17.70M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-03-31 | -$38.91M 10-Q · filed 2015-05-11 | -$43.85M derived: sum of 2 quarters · filed 2016-03-15 | -$33.40M derived: sum of 3 quarters · filed 2016-03-15 | -$39.71M derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2013-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $5.51M derived: sum of 2 quarters · filed 2016-03-15 | -$798.00K derived: sum of 3 quarters · filed 2016-03-15 | $7.91M 10-K · filed 2016-03-15 | ||
| 2013-09-30 | $10.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $4.14M derived: sum of 2 quarters · filed 2014-11-10 | $12.85M 10-Q · filed 2014-11-10 | $21.18M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | -$6.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.40M 10-Q · filed 2014-08-11 | $10.73M derived: sum of 3 quarters · filed 2015-03-16 | -$18.93M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $8.71M 10-Q · filed 2014-05-12 | $17.04M derived: sum of 2 quarters · filed 2015-03-16 | -$12.62M derived: sum of 3 quarters · filed 2015-03-16 | -$11.88M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$21.33M derived: sum of 2 quarters · filed 2015-03-16 | -$20.59M derived: sum of 3 quarters · filed 2015-03-16 | -$907.00K 10-K · filed 2015-03-16 | ||
| 2012-09-30 | -$29.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$28.92M derived: sum of 2 quarters · filed 2013-11-07 | -$9.24M 10-Q · filed 2013-11-07 | -$1.88M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | $742.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $20.42M 10-Q · filed 2013-08-09 | $27.78M derived: sum of 3 quarters · filed 2014-03-13 | $32.52M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | $19.68M 10-Q · filed 2013-05-09 | $27.04M derived: sum of 2 quarters · filed 2014-03-13 | $31.78M derived: sum of 3 quarters · filed 2014-03-13 | $38.27M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | $7.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $12.10M derived: sum of 2 quarters · filed 2014-03-13 | $18.59M derived: sum of 3 quarters · filed 2014-03-13 | $16.91M 10-K · filed 2014-03-13 | ||
| 2011-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $11.23M derived: sum of 2 quarters · filed 2012-11-09 | $9.55M 10-Q · filed 2012-11-09 | $2.50M derived: sum of 4 quarters · filed 2013-03-18 | -$32.49M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $6.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $4.81M 10-Q · filed 2012-08-07 | -$2.24M derived: sum of 3 quarters · filed 2013-03-18 | $4.90M derived: sum of 4 quarters · filed 2013-03-18 | -$37.24M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | -$1.68M 10-Q · filed 2012-05-10 | -$8.73M derived: sum of 2 quarters · filed 2013-03-18 | -$1.59M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $94.00K derived: sum of 2 quarters · filed 2013-03-18 | $19.92M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | $7.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $26.97M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $19.83M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | -$52.40M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |